Market Reports Center

Global Psoriasis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023


Report Details

Global Psoriasis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

SKU GIROCT291812
Category Pharmaceuticals
Publisher GlobalInfoResearch
Pages 132
Published Oct-18
Request Discount Pay by Wire/Invoice

Description

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, itchy, and scaly. Psoriasis varies in severity from small, localized patches to complete body coverage.



Scope of the Report:

This report focuses on the Psoriasis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Psoriasis Drugs is expected to grow at a CAGR of roughly 8.9% over the next five years, will reach 20900 million US$ in 2023, from 12600 million US$ in 2017, according to a new GIR (Global Info Research) study.



Market Segment by Manufacturers, this report covers

AbbVie

Amgen

Johnson & Johnson

Novartis

Eli Lilly

AstraZeneca

Celgene



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

TNF-inhibitors

Interleukin-inhibitors

Others



Market Segment by Applications, can be divided into

Hospital

Clinic



There are 15 Chapters to deeply display the global Psoriasis Drugs market.

Chapter 1, to describe Psoriasis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Psoriasis Drugs, with sales, revenue, and price of Psoriasis Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Psoriasis Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Psoriasis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Psoriasis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


News/Press Release

Table of Content

Table of Contents



1 Market Overview

1.1 Psoriasis Drugs Introduction

1.2 Market Analysis by Type

1.2.1 TNF-inhibitors

1.2.2 Interleukin-inhibitors

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Psoriasis Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Psoriasis Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson & Johnson

2.3.1 Business Overview

2.3.2 Psoriasis Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson & Johnson Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Psoriasis Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eli Lilly

2.5.1 Business Overview

2.5.2 Psoriasis Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eli Lilly Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 AstraZeneca

2.6.1 Business Overview

2.6.2 Psoriasis Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 AstraZeneca Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Celgene

2.7.1 Business Overview

2.7.2 Psoriasis Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Celgene Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Psoriasis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Psoriasis Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Psoriasis Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Psoriasis Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Psoriasis Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Psoriasis Drugs Market Analysis by Regions

4.1 Global Psoriasis Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Psoriasis Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Psoriasis Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.5 South America Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Psoriasis Drugs Sales and Growth Rate (2013-2018)

5 North America Psoriasis Drugs by Countries

5.1 North America Psoriasis Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Psoriasis Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Psoriasis Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Psoriasis Drugs Sales and Growth Rate (2013-2018)

6 Europe Psoriasis Drugs by Countries

6.1 Europe Psoriasis Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.3 UK Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.4 France Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Psoriasis Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Psoriasis Drugs by Countries

7.1 Asia-Pacific Psoriasis Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.5 India Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Psoriasis Drugs Sales and Growth Rate (2013-2018)

8 South America Psoriasis Drugs by Countries

8.1 South America Psoriasis Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Psoriasis Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Psoriasis Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Psoriasis Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Psoriasis Drugs by Countries

9.1 Middle East and Africa Psoriasis Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Psoriasis Drugs Sales and Growth Rate (2013-2018)

10 Global Psoriasis Drugs Market Segment by Type

10.1 Global Psoriasis Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Psoriasis Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Psoriasis Drugs Revenue and Market Share by Type (2013-2018)

10.2 TNF-inhibitors Sales Growth and Price

10.2.1 Global TNF-inhibitors Sales Growth (2013-2018)

10.2.2 Global TNF-inhibitors Price (2013-2018)

10.3 Interleukin-inhibitors Sales Growth and Price

10.3.1 Global Interleukin-inhibitors Sales Growth (2013-2018)

10.3.2 Global Interleukin-inhibitors Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Psoriasis Drugs Market Segment by Application

11.1 Global Psoriasis Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Psoriasis Drugs Market Forecast (2018-2023)

12.1 Global Psoriasis Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Psoriasis Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Psoriasis Drugs Market Forecast (2018-2023)

12.2.2 Europe Psoriasis Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Psoriasis Drugs Market Forecast (2018-2023)

12.2.4 South America Psoriasis Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Psoriasis Drugs Market Forecast (2018-2023)

12.3 Psoriasis Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Psoriasis Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Psoriasis Drugs Market Share Forecast by Type (2018-2023)

12.4 Psoriasis Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Psoriasis Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Psoriasis Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Figures

List of Tables and Figures



Figure Psoriasis Drugs Picture

Table Product Specifications of Psoriasis Drugs

Figure Global Sales Market Share of Psoriasis Drugs by Types in 2017

Table Psoriasis Drugs Types for Major Manufacturers

Figure TNF-inhibitors Picture

Figure Interleukin-inhibitors Picture

Figure Others Picture

Figure Psoriasis Drugs Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Clinic Picture

Figure United States Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Psoriasis Drugs Revenue (Value) and Growth Rate (2013-2023)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Psoriasis Drugs Type and Applications

Table AbbVie Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Psoriasis Drugs Type and Applications

Table Amgen Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Psoriasis Drugs Type and Applications

Table Johnson & Johnson Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Psoriasis Drugs Type and Applications

Table Novartis Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Psoriasis Drugs Type and Applications

Table Eli Lilly Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Psoriasis Drugs Type and Applications

Table AstraZeneca Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Psoriasis Drugs Type and Applications

Table Celgene Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Psoriasis Drugs Sales by Manufacturer (2016-2017)

Figure Global Psoriasis Drugs Sales Market Share by Manufacturer in 2016

Figure Global Psoriasis Drugs Sales Market Share by Manufacturer in 2017

Table Global Psoriasis Drugs Revenue by Manufacturer (2016-2017)

Figure Global Psoriasis Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Psoriasis Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Psoriasis Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Psoriasis Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Global Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Global Psoriasis Drugs Sales by Regions (2013-2018)

Table Global Psoriasis Drugs Sales Market Share by Regions (2013-2018)

Table Global Psoriasis Drugs Revenue by Regions (2013-2018)

Figure Global Psoriasis Drugs Revenue Market Share by Regions in 2013

Figure Global Psoriasis Drugs Revenue Market Share by Regions in 2017

Figure North America Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Europe Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure South America Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure North America Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table North America Psoriasis Drugs Sales by Countries (2013-2018)

Table North America Psoriasis Drugs Sales Market Share by Countries (2013-2018)

Figure North America Psoriasis Drugs Sales Market Share by Countries in 2013

Figure North America Psoriasis Drugs Sales Market Share by Countries in 2017

Table North America Psoriasis Drugs Revenue by Countries (2013-2018)

Table North America Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Psoriasis Drugs Revenue Market Share by Countries in 2013

Figure North America Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure United States Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Canada Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Europe Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Europe Psoriasis Drugs Sales by Countries (2013-2018)

Table Europe Psoriasis Drugs Sales Market Share by Countries (2013-2018)

Table Europe Psoriasis Drugs Revenue by Countries (2013-2018)

Figure Europe Psoriasis Drugs Revenue Market Share by Countries in 2016

Figure Europe Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure Germany Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure UK Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure France Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Russia Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Italy Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Psoriasis Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Psoriasis Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Psoriasis Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Revenue Market Share by Countries 2017

Figure China Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Japan Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Korea Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure India Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure South America Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table South America Psoriasis Drugs Sales by Countries (2013-2018)

Table South America Psoriasis Drugs Sales Market Share by Countries (2013-2018)

Figure South America Psoriasis Drugs Sales Market Share by Countries in 2017

Table South America Psoriasis Drugs Revenue by Countries (2013-2018)

Table South America Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure Brazil Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Psoriasis Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Psoriasis Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Psoriasis Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure UAE Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Psoriasis Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Psoriasis Drugs Sales and Growth Rate (2013-2018)

Table Global Psoriasis Drugs Sales by Type (2013-2018)

Table Global Psoriasis Drugs Sales Share by Type (2013-2018)

Table Global Psoriasis Drugs Revenue by Type (2013-2018)

Table Global Psoriasis Drugs Revenue Share by Type (2013-2018)

Figure Global TNF-inhibitors Sales Growth (2013-2018)

Figure Global TNF-inhibitors Price (2013-2018)

Figure Global Interleukin-inhibitors Sales Growth (2013-2018)

Figure Global Interleukin-inhibitors Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Psoriasis Drugs Sales by Application (2013-2018)

Table Global Psoriasis Drugs Sales Share by Application (2013-2018)

Figure Global Clinic Sales Growth (2013-2018)

Figure Global Psoriasis Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Psoriasis Drugs Sales Forecast by Regions (2018-2023)

Table Global Psoriasis Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Psoriasis Drugs Market Forecast (2018-2023)

Figure Europe Sales Psoriasis Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Psoriasis Drugs Market Forecast (2018-2023)

Figure South America Sales Psoriasis Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Psoriasis Drugs Market Forecast (2018-2023)

Table Global Psoriasis Drugs Sales Forecast by Type (2018-2023)

Table Global Psoriasis Drugs Market Share Forecast by Type (2018-2023)

Table Global Psoriasis Drugs Sales Forecast by Application (2018-2023)

Table Global Psoriasis Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Companies Profiled

AbbVie

Amgen

Johnson & Johnson

Novartis

Eli Lilly

AstraZeneca

Celgene

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl